|
Big Pharma Sees Profits, Not Patients: Support 340B Legislation To Stop Drugmakers From Skirting The Rules And Hurting Patients in Need
Tuesday, Oct 28, 2025 - Posted by Advertising Department [The following is a paid advertisement.] Every year is a banner year for pharmaceutical companies because every year they rake in billions of dollars in profits. At the same time, Big Pharma spends more on stock buybacks, dividends, and executive compensation than research and development. The numbers are eye-popping: over $112 billion in profits for 10 large drugmakers when 25% of Americans are unable to afford needed prescriptions. These drugmakers, many based overseas, charge Americans more for lifesaving medications than anyone else in the world. For example, the blood thinner Eliquis sold for $1,300 a year in the U.S. in 2013 compared with $1,000 in Japan. By 2024, Eliquis cost only $900 a year in Japan but $7,100 in the U.S. Overcharging Americans is part of Big Pharma’s business model centered on protecting their profits no matter who’s harmed in the process. In recent years, part of their strategy has been to flat-out flout the requirements of the federal 340B drug pricing program. They’re limiting access to the savings that hospitals pass onto patients in reduced prescription costs and lifesaving services. The hospitals participating in 340B care for large numbers of uninsured and low-income patients and include safety net hospitals and critical access hospitals. Vote YES on HB 2371 SA 2 to prevent Big Pharma from harming patients across Illinois. Learn more.
Comments Off |
|
It’s Time To Bring Safer Rides To Illinois
Tuesday, Oct 28, 2025 - Posted by Advertising Department [The following is a paid advertisement.] Waymo is ready to bring safe, reliable, autonomous rides to Illinois – but we need your help! Waymo is designed to follow all traffic laws and obey speed limits, and the data shows Waymo’s autonomous vehicles are involved in five times fewer injury-causing collisions compared to humans (as of 6/2025, see waymo.com/safety). Let’s bring safer rides to Illinois.  Waymo’s autonomous vehicles can improve access to transportation for Illinois residents with travel-limiting disabilities like vision impairment, to reach medical care, groceries, and social activities. Waymo’s all-electric autonomous vehicles also provide a more sustainable way for people to get around, preventing 315+ tons of carbon emissions with every 250K trips provided through our ride-hailing service.
Comments Off |
|
What Illinois Can Learn From Texas On Battery Energy Storage
Tuesday, Oct 28, 2025 - Posted by Advertising Department [The following is a paid advertisement.] As Illinois confronts skyrocketing electric bills, legislators are on the hunt for solutions that provide relief as quickly as possible. Battery energy storage is our best and most cost-effective solution. But last session— without evidence —opponents attempted to claim that battery energy storage wouldn’t work. Try telling that to Texas, where the rapid deployment of battery storage has already prevented blackouts and saved consumers billions. Called “Ground Zero for the US Battery Boom” by Bloomberg, Texas added enough storage in 2023 to power 3 million homes and drop grid emergency risk during peak hours from 16% to less than 1%. The result? Storage saved consumers an estimated $750 million in 2024. Texas has proven that storage is the quickest, cheapest, most reliable way to get consumers relief from skyrocketing, demand-induced price spikes. Storage is a nimble way to address growing populations, power-hungry data centers, and meet other electrification-related power needs. These are benefits Texas saw from storage even as the state reduced its gas generation capacity by 166 MW last year. Illinois lawmakers should follow Texas’s lead and pass the Clean and Reliable Grid Act this fall to deploy 6GW of energy storage by 2035. Click here for more information.
Comments Off |
|
Illinois’ Largest Medicaid Provider Exposes Big Pharma Disinformation Campaign: Here’s The Truth About UChicago Medicine And 340B Drug Discounts
Tuesday, Oct 28, 2025 - Posted by Advertising Department [The following is a paid advertisement.] For nearly 100 years, UChicago Medicine has delivered compassionate care to patients. Today, the integrated academic and community health system employs over 13,000 Illinoisans between its South Side and Harvey hospitals. Its physicians and nurses handle over 220,000 emergency room visits and 30,000 surgeries a year. They also care for many low-income and uninsured patients. As the state’s largest provider of Medicaid-insured care, University of Chicago Medical Center relies on the federal 340B program to provide critical care on the South Side, where residents face high rates of chronic disease and health disparities. UChicago Medicine redirects drug discount savings toward essential services and programs, including an expanded adult emergency department, new adult trauma center, and new state-of-the-art Center for Care and Discovery. Allowing drugmaker restrictions on 340B would put at risk many essential UChicago Medicine programs—its Level 1 trauma centers, neonatal ICU, the South Side’s only burn unit and more. UChicago Medicine is committed to serving Chicago’s South Side and Harvey, where 25% of residents live in poverty. In its 2024 fiscal year, the nonprofit system invested $715 million in community benefits and services for patients. As federal Medicaid cuts threaten the South Side’s healthcare ecosystem, 340B remains more important than ever to ensure access to high-quality care for communities in need. Vote YES on HB 2371 SA 2 to protect 340B. Learn more.
Comments Off |
| « NEWER POSTS | PREVIOUS POSTS » |
